help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivier, C.
Right arrow Articles by Brown, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivier, C.
Right arrow Articles by Brown, M.

Endocrinology, Vol 125, 3096-3102, Copyright © 1989 by Endocrine Society


ARTICLES

In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release

C Rivier, W Vale and M Brown
The Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, California 92037.

Recombinant interleukin-1 alpha and -beta (Il-1 alpha and -beta) have been evaluated for their abilities to stimulate ACTH and catecholamine secretion in the intact adult male rat. Additionally, the role of adrenergic-dependent pathways in mediating Il-1-induced ACTH release has been assessed. The iv or intracerebroventricular injection of either Il-1 alpha or Il-1 beta caused dose-related increases in plasma ACTH, epinephrine, and norepinephrine levels. While at low iv doses (less than or equal to 10 ng), Il-1 beta was more effective than Il-1 alpha at releasing ACTH, no measurable differences were noted at higher doses. In contrast, Il-1 beta was significantly more active at all doses in elevating plasma ACTH levels after intracerebroventricular injection. Similarly, Il-1 alpha was more effective than Il-1 beta at stimulating epinephrine, but not norepinephrine, secretion after icv injection. Because of the ability of catecholamines to alter ACTH secretion, we then examined the role of adrenergic-dependent pathways as possible mediators of Il-1-induced ACTH secretion. Blockade of adrenergic receptors by the concomitant administration of prazosin and propanolol prevented the simultaneous actions of phenylephrine and isoproterenol on the corticotrophs, but did not significantly alter the effect of peripherally administered Il-1 alpha on ACTH release. These results suggest that both Il-1 alpha and Il-1 beta stimulate ACTH and catecholamine secretion in the rat. Despite the ability of the lymphokine to elevate plasma epinephrine and norepinephrine values, circulating catecholamines do not appear to represent essential modulators of ACTH release induced by acutely injected Il-1.


This article has been cited by other articles:


Home page
FocusHome page
A. H. Miller and C. L. Raison
Immune System Contributions to the Pathophysiology of Depression
Focus, January 1, 2008; 6(1): 36 - 45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M.-F. O'Connor, S. J. Motivala, E. M. Valladares, R. Olmstead, and M. R. Irwin
Sex differences in monocyte expression of IL-6: role of autonomic mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R145 - R151.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. C. Schiltz and P. E. Sawchenko
Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults
J. Neurosci., July 1, 2002; 22(13): 5606 - 5618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F.-C. Chang and M. R. Opp
IL-1 is a mediator of increases in slow-wave sleep induced by CRH receptor blockade
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R793 - R802.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Ek, M. Kurosawa, T. Lundeberg, and A. Ericsson
Activation of Vagal Afferents after Intravenous Injection of Interleukin-1beta : Role of Endogenous Prostaglandins
J. Neurosci., November 15, 1998; 18(22): 9471 - 9479.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Ogilvie and C. Rivier
The Intracerebroventricular Injection of Interleukin-1{beta} Blunts the Testosterone Response to Human Chorionic Gonadotropin: Role of Prostaglandin- and Adrenergic-Dependent Pathways
Endocrinology, July 1, 1998; 139(7): 3088 - 3095.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. VENIHAKI, A. GRAVANIS, and A. N. MARGIORIS
KAT45 Human Pheochromocytoma Cell Line: A New Model for the In Vitro Study of Neuro-Immuno-Hormonal Interactions
Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
F. HAOUR, M. JAFARIAN-TEHRANI, M.-M. GABELLEC, M. CRUMEYROLLE-ARIAS, Y. HU, G. WICK, and T. TERNYNCK
Interleukin-1 Receptor Defect in Autoimmune NZB Mouse Brain
Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. H. Lang, J. Fan, M. M. Wojnar, T. C. Vary, and R. Cooney
Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R956 - R962.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. M. Reyes and C. L. Coe
The proinflammatory cytokine network: interactions in the CNS and blood of rhesus monkeys
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R139 - R144.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society